National MS Society Launched $1 Billion Campaign

The nonprofit organization seeks to fund critical research to find a cure for multiple sclerosis.

Updated on Oct. 1, 2026 in Stroke

Bold vector editorial illustration of a glowing orange neural filament inside a glass flask, symbolizing multiple sclerosis research. — The National Multiple Sclerosis Society has launched a $1 billion five-year fundraising campaign to accelerate medical research and expand access to patient care. AI Illustration. Upload story photo >

Live Poll

Should medical research funding prioritize finding permanent cures over managing chronic disease symptoms?

The National Multiple Sclerosis Society has launched a five-year fundraising campaign with a goal of $1 billion. This initiative aims to accelerate research breakthroughs and expand access to care for the nearly 1 million Americans currently living with the disease.

Why it matters

With no cure currently available for multiple sclerosis, this campaign intends to advance the Pathways to Cures roadmap. The funding will support the society's mission to drive innovation and provide better health outcomes for patients nationwide.

The society is awarding $8.9 million in new investments across 15 projects, adding to the 200 research initiatives it already supports worldwide. These efforts are intended to assist the estimated 1 million people in the United States living with MS.

The players

National Multiple Sclerosis Society

Founded in 1946, this organization supports global research and advocacy for people living with multiple sclerosis.

The details

The campaign will funnel capital into research projects specifically aligned with the Pathways to Cures roadmap. To mark the movement, iconic buildings in New York City are scheduled to illuminate in orange, a visual symbol of the organization's advocacy efforts.

The National MS Society was founded in 1946.
The Campaign to End MS launched on October 1, 2026.
NYC buildings will illuminate for the MS movement on October 3, 2026.

Stroke
Sept. 23
Drug Kamuvudine-9 Reversed MS Symptoms in Mice
Stroke
Sept. 30
FDA Accepted New Drug Application for Fenebrutinib
Alzheimer’s
Sept. 28
Michael J. Fox Foundation Surpassed $3 Billion in Funding

Deeper Dive

The campaign follows the strategic framework established by the Pathways to Cures roadmap. This initiative represents a significant scaling of the society's long-term efforts to bridge the gap between existing scientific knowledge and a cure for the disease.

The campaign aims to increase the number of treatment options and care resources available to the 1 million Americans currently managing MS. While the fundraising effort is long-term, it signals a commitment to expanding the scope of medical access for affected households.

The takeaway

Large-scale philanthropic efforts like this campaign are critical for funding high-risk, high-reward research in the absence of a cure. Readers can support these initiatives by engaging with local awareness events that keep the needs of the MS community in the public eye.